Henogen
Henogen was
created in 1999 at Charleroi, Belgium, as an
integrated bioengineering company active in the
development and clinical validation of new biotech
products for human health.Henogen can accompany new
partners and customers through the process
development, cGMP production and phase I/II
clinical trials of their new biotherapeutics. The
early 2003 acquisition of 4C Biotech, a contract
biomanufacturer dedicated to the development of
high density mammalian cell culture processes has
extended the service offer to the large scale cGMP
production of monoclonal antibodies. Today, the 70
people-strong company offers two R&D and
production sites featuring 3000 m2 facilities,
including 700 m2 GMP certified BL2 & BL3
suites, a park of 25 fermentors & bioreactors
ranging from 3L up to 300L as well as full DSP
tools, supervised by experienced QA & QC
departments .
|